Sachs-Bloomberg To Host Its Third Annual "Global Biotech Forum For Investing And Partnering"

BOSTON--(BUSINESS WIRE)--Feb. 2, 2004--Sachs Associates announced today that it will co-host, along with Bloomberg LP, its third annual "Sachs-Bloomberg Global Biotech Forum for Investing & Partnering," to be held April 1-2, 2004, at the Fairmont Copley Plaza hotel in Boston.

This two-day international event will bring together venture-funded and publicly traded companies with leading investors and pharmaceutical companies. Last year's event attracted more than 400 investors and business-development executives, along with 50 presenting companies.

"This year's forum will attract not only many of the world's most successful biotech investors but also many of the pharmaceutical industry's savviest business-development directors," said Leonard Sachs, Managing Director of Sachs Associates. "In short, this forum will serve as an excellent venue for companies that are looking for funding and partners."

Panel session topics will include: "Venture Financing Outlook for Biotech in 2004;" "Capital Markets;" "Evolving Pharma and Biotech Relationships;" "Fund of Funds;" "Global Development;" "Technology Transfer;" "Value Creation in Biotechnology;" "Assessing the Cost of Clinical Trials & Identifying the Key Issues in Drug Development;" "Systems Biology;" and "Emerging Markets."

In addition, a total of 50 privately held and publicly traded companies focused on the life sciences will make formal presentations about their business strategies and opportunities.

To register for the conference, contact Ms. Pernilla Hellsten at Pernilla@sachsforum.com.

The forum's co-sponsors include: AstraZeneca Pharmaceuticals; Fish & Richardson P.C.; Invest Australia; Katan Associates; and Kirkpatrick & Lockhart LLP.

The forum's partnering organizations include: BioExec Ventures LLC; GSAS Harvard Biotechnology Club; LaVoie Strategic Communications Group Inc.; Massachusetts Biotechnology Council; Ronald Trahan Associates Inc.; and, The Trout Group.

Since 1997, Sachs Associates, a London-based company that organizes and produces securities markets conferences, has been working in collaboration with Bloomberg LP, the fastest-growing electronic real-time financial information provider.

Business Wire is the official news service for the "Sachs-Bloomberg Global Biotech Forum for Investing & Partnering."

Contacts

Ronald Trahan Associates Inc. Ronald C. Trahan President/CEO 781-762-9782, ext. 18

Back to news